16 results
8-K
COGT
Cogent Biosciences Inc
22 Feb 21
Departure of Directors or Certain Officers
4:52pm
Pharmaceuticals, Inc. where he was responsible for finance, operations, and information systems during their pursuit of innovative therapies
8-K
EX-99.1
COGT
Cogent Biosciences Inc
14 Jun 19
Unum Therapeutics Strengthens and Expands Leadership Team
12:00am
companies throughout my career helping to bring innovative and transformative new therapies to patients, and am excited about Unum’s cutting-edge T cell
S-3
COGT
Cogent Biosciences Inc
2 Apr 19
Shelf registration
12:00am
their functionality. We see the BOXR technology as an important complement to the ACTR technology that further enhances the opportunity to develop innovative cell … technology as an important complement to the ACTR technology that further enhances the opportunity to develop innovative cell therapies in solid tumors
424B5
jwm94ig
2 Dec 20
Prospectus supplement for primary offering
5:06pm
424B5
whjnqsph7 apoe3b3s
30 Nov 20
Prospectus supplement for primary offering
5:28pm
10-K
n5siyf 5gh2qh2yhxkd
28 Mar 19
Annual report
7:31am
424B5
bdjwh
20 Mar 20
Prospectus supplement for primary offering
8:26am
- Prev
- 1
- Next